← Open Payments lookup

MIHAELA STOICA: Open Payments

NPI 1114238318 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,978 in 91 payments from 18 companies in 2025. Trend: 2023 $777 · 2024 $850 · 2025 $1,978

Food & beverage: $1,866Education: $111
CompanyPaymentsAmount
ABBVIE INC.23$325
Teva Pharmaceuticals USA, Inc.8$281
Alkermes, Inc.9$249
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$219
Corium, LLC8$206
Otsuka America Pharmaceutical, Inc.11$143
Lundbeck LLC4$116
Vanda Pharmaceuticals Inc.3$91
Supernus Pharmaceuticals, Inc.4$80
E.R. Squibb & Sons, L.L.C.4$75

Products named: VRAYLAR, REXULTI, CAPLYTA, Azstarys, ARISTADA, AUSTEDO XR, FANAPT, Qelbree.

Industry payments across TX — which companies pay providers there.